{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T12:29:12Z","timestamp":1667824152448},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,11,9]],"date-time":"2010-11-09T00:00:00Z","timestamp":1289260800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s12022-010-9138-3","type":"journal-article","created":{"date-parts":[[2010,11,8]],"date-time":"2010-11-08T08:46:55Z","timestamp":1289206015000},"page":"227-229","source":"Crossref","is-referenced-by-count":16,"title":["Low Immunohistochemical Expression of MGMT in ACTH Secreting Pituitary Tumors of Patients with Nelson Syndrome"],"prefix":"10.1007","volume":"21","author":[{"given":"Fateme","family":"Salehi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd W.","family":"Scheithauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica J.","family":"Moyes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William M.","family":"Drake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis V.","family":"Syro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Branavan","family":"Manoranjan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soniya","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Horvath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalman","family":"Kovacs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,11,9]]},"reference":[{"key":"9138_CR1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1530\/EJE-08-0557","volume":"160","author":"VJ Moyes","year":"2009","unstructured":"Moyes VJ, Alusi G, Sabin HI, Evanson J, Berney DM, Kovacs K, et al. Treatment of Nelson\u2019s syndrome with temozolomide. Eur J Endocrinol 160:115\u2013119, 2009.","journal-title":"Eur J Endocrinol"},{"key":"9138_CR2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.humpath.2006.07.014","volume":"38","author":"K Kovacs","year":"2007","unstructured":"Kovacs K, Horvath E, Syro LV, Uribe H, Penagos LC, Ortiz LD, et al. Temozolomide therapy in a man with an aggressive prolactin-secreting pituitary neoplasm: Morphological findings. Hum Pathol 38:185\u2013189, 2007.","journal-title":"Hum Pathol"},{"key":"9138_CR3","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s004280000373","volume":"438","author":"S Vidal","year":"2001","unstructured":"Vidal S, Kovacs K, Horvath E, Scheithauer BW, Kuroki T, Lloyd RV. Microvessel density in pituitary adenomas and carcinomas. Virchows Arch 438:595\u2013602, 2001.","journal-title":"Virchows Arch"},{"key":"9138_CR4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00401-007-0279-5","volume":"115","author":"K Kovacs","year":"2008","unstructured":"Kovacs K, Scheithauer BW, Lombardero M, McLendon RE, Syro LV, Uribe H, et al. MGMT immunoexpression predicts responsiveness of pituitary tumors to temozolomide therapy. Acta Neuropathol 115:261\u2013262, 2008.","journal-title":"Acta Neuropathol"},{"key":"9138_CR5","doi-asserted-by":"crossref","first-page":"E773","DOI":"10.1227\/01.NEU.0000339115.12803.4E","volume":"64","author":"S Mohammed","year":"2009","unstructured":"Mohammed S, Kovacs K, Mason W, Smyth H, Cusimano MD. Use of temozolomide in aggressive pituitary tumors: case report. Neurosurgery. 64:E773\u2013774, 2009.","journal-title":"Neurosurgery"},{"key":"9138_CR6","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1365-2265.2006.02653.x","volume":"65","author":"LV Syro","year":"2006","unstructured":"Syro LV, Uribe H, Penagos LC, Ortiz LD, Fadul CE, Horvath E, et al. Antitumour effects of temozolomide in a man with a large, invasive prolactin-producing pituitary neoplasm. Clin Endocrinol (Oxf) 65: 552\u2013553, 2006.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9138_CR7","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2174\/187152008784220276","volume":"8","author":"I Casorelli","year":"2008","unstructured":"Casorelli I, Russo MT, Bignami M. Role of mismatch repair and MGMT in response to anticancer therapies. Anticancer Agents Med Chem 8:368\u2013380, 2008.","journal-title":"Anticancer Agents Med Chem"},{"key":"9138_CR8","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/jjco\/hym132","volume":"37","author":"M Nagane","year":"2007","unstructured":"Nagane M, Kobayashi K, Ohnishi A, Shimizu S, Shiokawa Y. Prognostic significance of O6-methylguanine-DNA methyltransferase protein expression in patients with recurrent glioblastoma treated with temozolomide. Jpn J Clin Oncol 37:897\u2013906, 2007.","journal-title":"Jpn J Clin Oncol"},{"key":"9138_CR9","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1200\/JCO.2006.05.7265","volume":"24","author":"IF Pollack","year":"2006","unstructured":"Pollack IF, Hamilton RL, Sobol RW, Burnham J, Yates AJ, Holmes EJ, et al. O6-methylguanine-DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas: results from the CCG-945 Cohort. J Clin Oncol 24:3431\u20133437, 2006.","journal-title":"J Clin Oncol"},{"key":"9138_CR10","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1200\/JCO.2006.07.4807","volume":"25","author":"OL Chinot","year":"2007","unstructured":"Chinot OL, Barrie M, Fuentes S, Eudes N, Lancelot S, Metellus P, et al. Correlation between O6-methylguanine-DNA methyltransferase and survival in inoperable newly diagnosed glioblastoma patients treated with neoadjuvant temozolomide. J Clin Oncol 25:1470\u20131475, 2007.","journal-title":"J Clin Oncol"},{"key":"9138_CR11","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa043331","volume":"352","author":"ME Hegi","year":"2005","unstructured":"Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352:997\u20131003, 2005.","journal-title":"N Engl J Med"},{"key":"9138_CR12","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.3171\/foc.2007.23.3.15","volume":"23","author":"MJ Banasiak","year":"2007","unstructured":"Banasiak MJ, Malek AR. Nelson syndrome: comprehensive review of pathophysiology, diagnosis, and management. Neurosurg Focus 23:E13, 2007.","journal-title":"Neurosurg Focus"},{"key":"9138_CR13","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1365-2265.2008.03487.x","volume":"71","author":"AI McCormack","year":"2009","unstructured":"McCormack AI, McDonald KL, Gill AJ, Clark SJ, Burt MG, Campbell KA, et al. Low O6-methylguanine-DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumours. Clin Endocrinol (Oxf) 71:226\u2013233, 2009.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9138_CR14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.14310\/horm.2002.1247","volume":"8","author":"LV Syro","year":"2009","unstructured":"Syro LV, Scheithauer BW, Ortiz LD, Fadul CE, Horvath E, Rotondo F, et al. Effect of temozolomide in a patient with recurring oncocytic gonadotroph pituitary adenoma. Hormone (Athens) 8:303\u2013306, 2009.","journal-title":"Hormone (Athens)"}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-010-9138-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12022-010-9138-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-010-9138-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T02:01:03Z","timestamp":1559440863000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12022-010-9138-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,9]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["9138"],"URL":"https:\/\/doi.org\/10.1007\/s12022-010-9138-3","relation":{},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"value":"1046-3976","type":"print"},{"value":"1559-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,9]]}}}